Background. Inflammatory bowel diseases (IBD) are characterized by periods of remission with recurrent episodes of symptom exacerbation because of acute intesti
1 October 2008 in Journal of Pediatric Gastroenterology and Nutrition
Background. Some reports highlight the potential application of fecal calprotectin as a direct biomarker of intestinal inflammation and, therefore, as support i